02/12/2025
12:59 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
2:13 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
9:49 AM | Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
12:09 PM | Apellis Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
01/30/2025
11:13 AM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:15 AM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:18 AM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:20 AM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:01 AM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:03 AM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:07 AM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for APLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/30/2025
11:10 AM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:12 AM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
2:42 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:18 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:22 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:26 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:11 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:12 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:16 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:16 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:17 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
2:37 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:39 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:41 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:23 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:25 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:26 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:28 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:29 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:31 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:19 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:00 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:39 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:42 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:43 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:44 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:45 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:45 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:51 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:52 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
01/22/2025
2:56 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
2:56 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
2:59 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
2:54 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
3:38 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:20 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:27 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:29 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:22 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:25 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:29 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:30 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:09 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:10 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:14 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:15 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:55 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
4:56 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:00 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:02 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:02 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:05 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:07 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:09 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:13 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:15 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
8:08 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:38 PM | Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/10/2025
4:39 PM | Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:03 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
2:17 PM | Apellis Pharmaceuticals (Subject)
Baumal Caroline (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
3:06 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:48 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
3:16 PM | Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/22/2024
7:47 AM | Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G | |
11/08/2024
4:31 PM | Apellis Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/08/2024
9:52 AM | Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/05/2024
5:57 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
5:43 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:15 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:20 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:21 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
2:22 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:13 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:06 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:02 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
6:34 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:50 PM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
05/14/2024
7:09 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:15 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
4:13 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
6:02 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
6:27 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:25 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:17 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
10:24 AM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:18 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
